hematologic diseases
Part of Hematology
🏥1Companies
Companies in hematologic diseases
Note, this image was autogenerated by Syggy based on what we know about the company. It is not an official company publication.
Acceleron
Cambridge, Massachusetts, United States
Acceleron was a biopharmaceutical therapies company acquired by Merck in 2021.
Business ModelB2B, focused on discovery, development, and commercialization of biotherapeutics, generating revenue through collaboration, licensing, and research arrangements with partners like Celgene (now Bristol Myers Squibb).
Core TechExploiting the therapeutic potential of the transforming ...
Funding$493.0M
Founded2003
Drug Discovery/Development
59
Related Companies
Semantically similar companies discovered by AI
0
06-Mobile Thrombosis Prediction
Easy-use mobile platform for thrombosis prediction
Cardiovascular Disease
3
P
Proteome molecular profiling for discovery and diagnosis
Our technology reveals states, like cancerous or not, or drug responder or not. We do this by detecting many (10s of 1000s) of proteins and their variations and applying advance...
...morePrecision Medicine/Diagnostics
24